Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-04

Clinical Trial Update: Treatment of OSA Associated Hypertension With Alpha 2 Agonist or Diuretic [Phase 4]

View source ↗

Summary

Phase 4 trial update on treating obstructive sleep apnea–associated hypertension with an alpha-2 agonist or a diuretic; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of California, San Diego | Conditions: Obstructive Sleep Apnea | Phase 4 | Status: COMPLETED | Results posted: 2020-12-04